SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950142-15-002460
Filing Date
2015-11-19
Accepted
2015-11-19 17:29:34
Documents
2
Group Members
POINTSTATE CAPITAL LPSTEELMILL MASTER FUND LPZACHARY J. SCHREIBER

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G eh1501355_13g-clovis.htm SC 13G 140463
2 EXHIBIT 99.1 eh1501355_ex9901.htm EX-99.1 5860
  Complete submission text file 0000950142-15-002460.txt   147946
Mailing Address 2525 28TH STREET SUITE 100 BOULDER CO 80301
Business Address 2525 28TH STREET SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Subject) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-86488 | Film No.: 151244458
SIC: 2834 Pharmaceutical Preparations

Mailing Address 40 WEST 57TH STREET 25TH FLOOR NEW YORK NY 10019
Business Address 40 WEST 57TH STREET 25TH FLOOR NEW YORK NY 10019 (212) 830-7000
PointState Capital LP (Filed by) CIK: 0001509842 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G